Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed improvement in OS and Progression Free Survival (“PFS”) Clinical Benefit Rate (“CBR”) was 59.4% (n=32), comprised of 18 subjects with stable disease and 1 subject with a partial response Potential to address 13,500 new incidents of STS each year and market opportunity expected to grow to $2.6B by 20301 On-demand video we ...

Simply put, Alexandria Real Estate Equities Inc. (NYSE: ARE ), a REIT that leases lab space to life science companies, has become too cheap to ignore. The stock now offers a 7.5% dividend yield and has a forward price/FFO ratio of 7.6x. Further, whenI objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story (most of the time), as they tend to paint ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

ONTARIO, Calif., June 4, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an Agreement with Hybridfi Inc. ("Consultant" or "Hybridifi") for the design of the Company's Digital Asset Treasury Program. Hybridifi will design a Digital Asset Treasury Program for Nature's Miracle with the aim of bringing together the benefits of cash management solutions powered by bloc ...

Ordinær generalforsamling i Mowi ASA ble avholdt 4. juni og alle de foreslåtte sakene på agendaen ble godkjent. Protokollen fra generalforsamlingen er vedlagt. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12. Attachment Mowi ASA OGF protokoll 2025 final ...

The Annual General Meeting in Mowi ASA was held on 4 June and all items proposed on the agenda were adopted. An office translation of the minutes from the AGM is attached. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Mowi ASA - AGM minutes 2025vF ...

Telos Automated Message Handling System to support the DISA Organizational Messaging Service over this five-year contractASHBURN, Va., June 04, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it was awarded the Defense Information System Agency (DISA) Organizational Messaging Branch contract in support of the DISA Organizational Messaging Service (OMS) Te ...

Group 1 - Michael Wiggins De Oliveira is an inflection investor, focusing on buying undervalued companies at pivotal moments when their profitability is expected to improve significantly over the next year [1] - The investment strategy emphasizes technology and the Great Energy Transition, including uranium, with a concentrated portfolio of approximately 15 to 20 stocks and an average holding period of 18 months [1] - Michael has over 10 years of experience analyzing companies in tech and energy sectors, and has built a following of over 40,000 on Seeking Alpha [2] Group 2 - The Investing Group Deep Value Returns, led by Michael, offers insights through its concentrated portfolio of value stocks, timely updates on stock picks, and a weekly webinar for live advice [3] - The group provides "hand-holding" support for both new and experienced investors, fostering an active and kind community accessible via chat [3]

I wrote about Asana (NYSE: ASAN ) previously with a hold rating, as I thought it would be safer to invest in ASAN when the business starts to show positive growth inflection. Despite the pockets of strength in 1Q26—mostI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investing ...

Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral Lichen Planus, a condition with no approved treatmentsPITTSBURGH, June 04, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it has re-signed its manufacturing collaboration agreement with Cook MyoSite, Inc. (“Cook ...